Recovery article

Melanotan I for Sale From $33.99 — 5 Vendors (Jul 2026)

Disclosure: We earn a commission from vendors on this page. Rankings are based on objective criteria including price, COA availability, and reputation. Best Melanotan I Vendors of 2026 Ranked by Price, Purity, and Reputation Get Price Drop Alerts We'll email y

By Recovery & Performance Peptides Editorial Team Published July 13, 2026

Disclosure: We earn a commission from vendors on this page. Rankings are based on objective criteria including price, COA availability, and reputation.

Best Melanotan I Vendors of 2026

Ranked by Price, Purity, and Reputation

Get Price Drop Alerts

We'll email you when Melanotan I prices drop or vendors run sales.

Quick Comparison

Ascension Peptides50% OFF—THEPEPTIDECATALOGCopy

Yes

10/10

10mg$50.00$5.00/mgView →

Ion Peptide15% OFF—thepeptidecatalogCopy

9.5/10

10mg$35.00$3.50/mgView →

EZ Peptides10% OFF—thepeptidecatalogCopy

9.1/10

10mg$44.00$4.40/mgView →

Glacier Aminos10% OFF—thepeptidecatalogCopy

9/10

10mg$33.99$3.40/mgView →

Mile High Compounds10% OFF—thepeptidecatalogCopy

8.8/10

10mg$39.99$4.00/mgView →

Compare More Peptide Vendors

How We Score Vendors

Our scoring is based on three weighted factors:

Price Competitiveness (40%)

Normalized to cost per milligram for fair comparisons across vial sizes.

COA Availability (30%)

Third-party lab testing confirming purity, identity, and absence of contaminants.

Vendor Reputation (30%)

Community feedback, shipping reliability, customer service, and business track record.

Best Deal on Melanotan I →

All vendors sorted by $/mg — find the best deal

Calculate the Cost of Your Melanotan I Cycle →

Pick your dose and duration — see the total with supplies

Best Melanotan II Vendors of 2026 →

Ranked by price, purity testing, and buyer trust

Calculate the Cost of Your Melanotan II Cycle →

CONNECTED / MODULES

Post-session references

Selected from shared article topics. Source links are retained where available.

COACH'S BOARD / KEY POINTS

Regulatory Status: Afamelanotide (brand: Scenesse) is an FDA-approved prescription drug as of October 2019, indicated for adults with erythropoietic protoporphyria (EPP) to increase pain-free sun exposure. The European Medicines Agency approved it in 2014. As of April 2026, no indication exists for cosmetic tanning.
Research Stage: Landmark Phase 3 RCT published in the New England Journal of Medicine in 2015; substantial post-approval real-world effectiveness data available.
Availability: FDA-approved prescription-only subcutaneous implant. Available only through licensed prescribers in the US for the approved EPP indication. Superpower does not offer this medication.
What it is: A synthetic, protease-resistant analog of alpha-melanocyte-stimulating hormone (α-MSH) that selectively binds the MC1R receptor to stimulate eumelanin production and photoprotection.
What the evidence actually shows: In the 2015 pivotal RCT, EPP patients receiving afamelanotide tolerated significantly more direct sun exposure and reported meaningfully better quality of life versus placebo. Published in the New England Journal of Medicine in 2015.
Prescribing information: PubChem CID 2656580

SOURCE / superpower.com ↗

Handling & safety lane

Source-derived education, not individual medical guidance or an instruction to dose.

DOSAGE SOURCE

Melanotan-I Dosage, Reconstitution & Mixing Trends

Explore Melanotan-I (afamelanotide) dosage trends, reconstitution volumes, and vial size patterns from anonymized WPA peptide calculator sessions. Melanotan-I (afamelanotide) is a potent, MC1-selective alpha-MSH analog approved in implant form as SCENESSE for the prevention of phototoxicity in adults with erythropoietic protoporphyria (EPP). It shares a research origin with Melanotan II at the University of Arizona but followed a fundamentally different commercial path. This data shows the dose amounts, vial sizes, and diluent volumes researchers most commonly select when working with Melanotan-I. 144 Melanotan-I reconstitution calculations have been logged by the WPA community. The most common dose entered is 250mcg (46 calculations). The median dose across all sessions is 300mcg. The most common bacteriostatic water volume is 2mL. The most popular vial size is 10mg (134 sessions). The most common dosing frequency is daily (7x/week) (10 logged protocols), followed by 2x/week (8). World Peptide Association aggregates anonymized peptide calculator data to show real-world dosing trends, reconstitution volumes, and vial size preferences across the research peptide community. All figures shown are aggregated from anonymized calculator inputs and are provided strictly for independent laboratory research and educational purposes. They are community usage statistics — not dosing recommendations, and not medical advice.

Evidence cooldown

Research context and source excerpts for a slower second read.

RESEARCH

Community Research

Join others researching Melanotan I — share findings, ask questions, and learn from real experiences Synthetic analog of α-MSH that selectively targets MC1 receptors for melanin stimulation. FDA-approved as SCENESSE implant for erythropoietic protoporphyria (EPP). Research-grade injectable form enables flexible dosing versus the implant version. Subcutaneous injection delivers peptide directly into systemic circulation. Selectively activates MC1R receptors to stimulate melanin production. Short half-life of approximately 30 minutes necessitates multiple daily dosing for sustained effect.

POTENTIAL BENEFITS

What Are the Benefits of Melanotan I?

By supporting melanocyte activity and melanin production, Melanotan I may offer several aesthetic and wellness-focused benefits, including:

Product & matchup locker

Linked catalog and comparison files.

Comparison

What This Melanotan-I Comparison Page Includes

Live Melanotan-I pricing — Current prices across all tracked vendors, normalized to price per milligram for a fair apples-to-apples comparison regardless of vial size. COA verific…